In Staphylococcus epidermidis and Staphylococcus aureus, non-specific DNase activity of the type III-A CRISPR–Cas system increases the rate of mutations in the host and accelerates the evolution of resistance to antibiotics and to phage.
- Charlie Y. Mo
- Jacob Mathai
- Luciano A. Marraffini
